1. Home
  2. MUJ vs EYPT Comparison

MUJ vs EYPT Comparison

Compare MUJ & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings New Jersey Quality Fund Inc.

MUJ

Blackrock MuniHoldings New Jersey Quality Fund Inc.

HOLD

Current Price

$12.01

Market Cap

631.8M

Sector

Finance

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$18.06

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUJ
EYPT
Founded
1998
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
631.8M
1.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
MUJ
EYPT
Price
$12.01
$18.06
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$29.60
AVG Volume (30 Days)
108.0K
1.3M
Earning Date
01-01-0001
11-05-2025
Dividend Yield
4.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$42,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.74
$3.91
52 Week High
$11.70
$19.11

Technical Indicators

Market Signals
Indicator
MUJ
EYPT
Relative Strength Index (RSI) 52.66 63.70
Support Level $11.96 $16.52
Resistance Level $12.15 $19.00
Average True Range (ATR) 0.09 1.15
MACD -0.01 0.08
Stochastic Oscillator 18.18 74.31

Price Performance

Historical Comparison
MUJ
EYPT

About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.

BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: